Analyst Reco. Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 11/07/2025 pm IST			5-day change	1st Jan Change
1,378.00 ^DKK	-1.18%		+6.12%	-7.67%

11/07	Baptista Research Begins Genmab Coverage at Outperform	MT
01/07	Genmab Announces Changes to Its Executive Committee	CI

Analyst Reco.

Baptista Research Begins Genmab Coverage at Outperform	11/07	MT
UBS Lowers Price Target for Genmab to 2,500 Danish Kroner, Reiterates Buy Recommendation	25/06	FW
GENMAB : Beaten up share price offers an opportunity	06/06
RBC lowers target price for Genmab to DKK 2,000 (2,300), reiterates outperform rating - BN	30/05	FW
RBC Cuts Price Target on Genmab to DKK2,000 From DKK2,300, Keeps Outperform Rating	29/05	MT
Deutsche Bank lowers target price for Genmab to DKK 1,750 (1,900), reiterates buy recommendation	23/05	FW
Redburn lowers target price for Genmab to DKK 2,700 (2,750), reiterates buy recommendation - BN	23/05	FW
UBS lowers target price for Genmab to DKK 2,600 (2,700), reiterates buy recommendation	12/05	FW
GENMAB : Mixed Q1; guidance maintained	10/05
Nordea Bank Upgrades Genmab to Buy	09/05	MT
Nykredit lowers target price for Genmab to DKK 1,750 (2,000), reiterates buy recommendation - BN	09/05	FW
Nordea raises Genmab to buy (hold), target price SEK 2,009	09/05	FW
Goldman Sachs raises target price for Genmab to DKK 1,785 (1,764), reiterates neutral rating - BN	09/05	FW
Carnegie raises target price for Genmab to DKK 2,288 (2,263), reiterates buy recommendation - BN	09/05	FW
Cowen lowers target price for Genmab to DKK 1,360 (1,431), reiterates hold rating - BN	09/05	FW
Svenska Handelsbanken Upgrades Genmab to Buy, Boosts PT	07/05	MT
Handelsbanken raises Genmab to buy (hold), target price SEK 2,000 (1,350)	07/05	FW
Carnegie lowers target price for Genmab to DKK 2,263 (2,491), reiterates buy recommendation - BN	06/05	FW
HSBC lowers target price for Genmab to DKK 1,990 (2,970), reiterates buy recommendation - BN	28/04	FW
Goldman Sachs lowers target price for Genmab to DKK 1,764 (1,841), reiterates neutral - BN	22/04	FW
BNP Paribas Exane lowers target price for Genmab to DKK 1,300 (1,400), reiterates neutral - BN	16/04	FW
Bernstein Downgrades Genmab to Underperform, Cuts PT	01/04	MT
Bernstein downgrades Genmab to underperform (market perform), target price DKK 1,000 (1,580) - BN	01/04	FW
BNP Paribas Exane lowers target price for Genmab to DKK 1,400 (1,500), reiterates neutral - BN	12/03	FW
William Blair Upgrades Genmab to Outperform From Market Perform	11/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : Beaten up share price offers an opportunity

June 06, 2025 at 06:10 pm IST

Genmab: From now on, courage to the most patient

April 01, 2025 at 08:27 pm IST